Clinical Trial

Hemostasis in Liver Cirrhosis and Hepatocellular Cancer

Study acronym: HELICS
Recruiting
View on ClinicalTrials.gov →
Summary
Evaluating hemostasis in decompensated liver cirrhosis with novel hemostatic assays.
Trial Details
NCT Number NCT06212635
Lead Sponsor Region Stockholm
Collaborators: Sahlgrenska University Hospital
Conditions Hemostasis in Decompensated Liver Cirrhosis, Inflammation in Decompensated Liver Cirrhosis
Enrollment 100 participants
Start Date 2022-12-02
Primary Completion 2026-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-01-19